O. Janha

Development of Potent PfCLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials

A. Tobin, D. Nwakanma, A. Amambua-Ngwa, 2020, Journal of medicinal chemistry.

Development of Potent and Selective PfCLK3 Inhibitors Based on GSK-TCMDC151 as a New Class of Antimalarials

A. Tobin, Amit Mahindra, A. Jamieson, 2019 .

Population Genomic Scan for Candidate Signatures of Balancing Selection to Guide Antigen Characterization in Malaria Parasites

D. Kwiatkowski, D. Conway, M. Jallow, 2012, PLoS genetics.

Killer-cell immunoglobulin-like receptors and malaria caused by Plasmodium falciparum in The Gambia

D. Conway, M. Jallow, P. Aka, 2012, Tissue antigens.

Validation of the protein kinase PfCLK3 as a multi-stage cross species malarial drug target

E. Winzeler, F. Gamo, A. Tobin, 2018, bioRxiv.

Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction

B. Hudson, R. Touyz, A. Tobin, 2021, PloS one.

On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey

U. d’Alessandro, K. P. Grietens, D. Nwakanma, 2015, Malaria Journal.

Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target

E. Winzeler, F. Gamo, A. Tobin, 2019, Science.